Use of Prothrombin Complex Concentrates for Urgent Reversal of Dabigatran in the Emergency Department

Overview

Journal Haematologica

Specialty Hematology

Date 2013 Nov 5

PMID 24186317

Citations 8

Authors

Manuel Quintana Diaz

Alberto M Borobia

MA Angelica Rivera Nunez

Ana Maria Martinez Virto

Sara Fabra

Marcelino Sanchez Casado

Jose A Garcia-Erce

C Meyer Samama

Affiliations

Soon will be listed here.

Citing Articles

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Hoffman M, Goldstein J, Levy J Int J Emerg Med. 2019; 11(1):55.

PMID: 31179943 PMC: 6326120. DOI: 10.1186/s12245-018-0215-6.

Direct Oral Anticoagulants in Emergency Trauma Admissions.

Maegele M, Grottke O, Schochl H, Sakowitz O, Spannagl M, Koscielny J Dtsch Arztebl Int. 2016; 113(35-36):575-82.

PMID: 27658470 PMC: 5963488. DOI: 10.3238/arztebl.2016.0575.

Management of bleeding in patients treated with direct oral anticoagulants.

Levi M Crit Care. 2016; 20:249.

PMID: 27543264 PMC: 4992194. DOI: 10.1186/s13054-016-1413-3.

Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants.

Faraoni D, Levy J, Albaladejo P, Samama C Crit Care. 2015; 19:203.

PMID: 25925382 PMC: 4414429. DOI: 10.1186/s13054-015-0930-9.

Use of 4-factor prothrombin complex concentrate in the treatment of a gastrointestinal hemorrhage complicated by dabigatran.

McGovern T, McNamee J, Malabanan C, Fouad M, Patel N Int J Emerg Med. 2015; 8:10.

PMID: 25918557 PMC: 4401481. DOI: 10.1186/s12245-015-0059-2.

References

Schulman S, Kearon C, Kakkar A, Mismetti P, Schellong S, Eriksson H . Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009; 361(24):2342-52. DOI: 10.1056/NEJMoa0906598. View

van Ryn J, Baruch L, Clemens A . Interpretation of point-of-care INR results in patients treated with dabigatran. Am J Med. 2012; 125(4):417-20. DOI: 10.1016/j.amjmed.2011.10.017. View

Eerenberg E, Kamphuisen P, Sijpkens M, Meijers J, Buller H, Levi M . Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011; 124(14):1573-9. DOI: 10.1161/CIRCULATIONAHA.111.029017. View

van Ryn J, Stangier J, Haertter S, Liesenfeld K, Wienen W, Feuring M . Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010; 103(6):1116-27. DOI: 10.1160/TH09-11-0758. View

Pisters R, Lane D, Nieuwlaat R, de Vos C, Crijns H, Lip G . A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138(5):1093-100. DOI: 10.1378/chest.10-0134. View

Lambourne M, Eltringham-Smith L, Gataiance S, Arnold D, Crowther M, Sheffield W . Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost. 2012; 10(9):1830-40. DOI: 10.1111/j.1538-7836.2012.04863.x. View

Clemens A, van Ryn J, Sennewald R, Yamamura N, Stangier J, Feuring M . Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol. 2012; 68(5):607-16. PMC: 3332339. DOI: 10.1007/s00228-011-1205-2. View

Lillo-Le Louet A, Wolf M, Soufir L, Galbois A, Dumenil A, Offenstadt G . Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Thromb Haemost. 2012; 108(3):583-5. DOI: 10.1160/TH12-03-0149. View

Kansal A, Sorensen S, Gani R, Robinson P, Pan F, Plumb J . Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart. 2012; 98(7):573-8. PMC: 3308473. DOI: 10.1136/heartjnl-2011-300646. View

10.

Cao Y, Zhang J, Shen H, Jiang Y . Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2010; 66(11):1099-108. DOI: 10.1007/s00228-010-0889-z. View

11.

Pragst I, Zeitler S, Doerr B, Kaspereit F, Herzog E, Dickneite G . Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model. J Thromb Haemost. 2012; 10(9):1841-8. DOI: 10.1111/j.1538-7836.2012.04859.x. View